Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Improving Diagnosis and Treatment of Cardiovascular Disease

By HospiMedica International staff writers
Posted on 02 Sep 2008
A new European Union- (EU)-funded research project is aimed at improving the personalized diagnosis, therapy, planning, and treatment of cardiovascular disease--one of the biggest causes of mortality in the western world. More...


The ‘euHeart' project's purpose is the development of virtual versions of people's hearts, so that doctors can make the best decisions for their patients before performing minimally invasive surgery. The technology will also map the unique electrical and muscle activity within the heart, so that clinicians should be able to work out the likely impact of different treatment options. It is predicted the models could help improve treatment of patients with heart failure (HF), coronary artery disease (CAD), and congenital heart defects.

Another area in which the technology could be useful is in the case of rhythm disorders treated by radiofrequency (RF) ablation. Currently doctors rely on their own experience to decide which areas to target; however, this is a serious challenge since the electrical activity in each person's heart is subtly different. With a computer model that perfectly matches the patient's anatomy and mimics the electrical activity of their heart, doctors could know in advance the likely impact of destroying specific areas of tissue and work out the likely success of the treatment for a patient. The virtual heart models are created by combining data from existing diagnostic technologies such as computerized tomography (CT), magnetic resonance imaging (MRI), and electrocardiograms (ECGs), as well as blood flow and pressure measurements in the coronary arteries.

"In the euHeart project we are confident that we can make a real contribution to improving the treatment of one of the most important world's killer diseases,” said Henk van Houten, senior vice president of Philips Research (Amsterdam, The Netherlands) and head of the euHeart healthcare research program. "The development of computer models that integrate structural and functional information of the heart and then personalize it to individual patients is a mammoth task that will require the multi-disciplinary effort of researchers with strong know-how in biophysical modeling and image processing, clinical experts, and engineers in the device and imaging industries.”

The euHeart project involves public and private partners from 16 research, academic, industrial, and medical organizations from six different European countries--Belgium, France, Germany, the Netherlands, Spain, France, and the United Kingdom. The project will run for four years and has a budget of EUR 19 million.

Related Links:
Philips Research


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.